These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23046564)

  • 1. Comparison between the AA/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters.
    Rizzo AM; Corsetto PA; Montorfano G; Opizzi A; Faliva M; Giacosa A; Ricevuti G; Pelucchi C; Berra B; Rondanelli M
    Nutr J; 2012 Oct; 11():82. PubMed ID: 23046564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long chain omega 3 polyunsaturated fatty acids supplementation in the treatment of elderly depression: effects on depressive symptoms, on phospholipids fatty acids profile and on health-related quality of life.
    Rondanelli M; Giacosa A; Opizzi A; Pelucchi C; La Vecchia C; Montorfano G; Negroni M; Berra B; Politi P; Rizzo AM
    J Nutr Health Aging; 2011 Jan; 15(1):37-44. PubMed ID: 21267525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial.
    Rondanelli M; Giacosa A; Opizzi A; Pelucchi C; La Vecchia C; Montorfano G; Negroni M; Berra B; Politi P; Rizzo AM
    J Am Coll Nutr; 2010 Feb; 29(1):55-64. PubMed ID: 20595646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression.
    Adams PB; Lawson S; Sanigorski A; Sinclair AJ
    Lipids; 1996 Mar; 31 Suppl():S157-61. PubMed ID: 8729112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial.
    Sinn N; Milte CM; Street SJ; Buckley JD; Coates AM; Petkov J; Howe PR
    Br J Nutr; 2012 Jun; 107(11):1682-93. PubMed ID: 21929835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS; Conquer JA; Thomas R
    Reprod Nutr Dev; 2005; 45(5):549-58. PubMed ID: 16188207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the association between whole blood Omega-3 Index, DHA, EPA, DHA, AA and n-6 DPA, and depression and self-esteem in adolescents of lower general secondary education.
    van der Wurff ISM; von Schacky C; Bergeland T; Leontjevas R; Zeegers MP; Kirschner PA; de Groot RHM
    Eur J Nutr; 2019 Jun; 58(4):1429-1439. PubMed ID: 29549496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid method for determining arachidonic:eicosapentaenoic acid ratios in whole blood lipids: correlation with erythrocyte membrane ratios and validation in a large Italian population of various ages and pathologies.
    Rizzo AM; Montorfano G; Negroni M; Adorni L; Berselli P; Corsetto P; Wahle K; Berra B
    Lipids Health Dis; 2010 Jan; 9():7. PubMed ID: 20105293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3/omega-6 fatty acid ratios in different phospholipid classes and depressive symptoms in coronary artery disease patients.
    Mazereeuw G; Herrmann N; Ma DWL; Hillyer LM; Oh PI; Lanctôt KL
    Brain Behav Immun; 2016 Mar; 53():54-58. PubMed ID: 26697998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
    Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
    Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential therapeutic impact of omega-3 long chain-polyunsaturated fatty acids on inflammation markers in Duchenne muscular dystrophy: A double-blind, controlled randomized trial.
    Rodríguez-Cruz M; Cruz-Guzmán ODR; Almeida-Becerril T; Solís-Serna AD; Atilano-Miguel S; Sánchez-González JR; Barbosa-Cortés L; Ruíz-Cruz ED; Huicochea JC; Cárdenas-Conejo A; Escobar-Cedillo RE; Yam-Ontiveros CA; Ricárdez-Marcial EF
    Clin Nutr; 2018 Dec; 37(6 Pt A):1840-1851. PubMed ID: 28987470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements.
    Carney RM; Steinmeyer BC; Freedland KE; Rubin EH; Rich MW; Harris WS
    J Clin Psychiatry; 2016 Feb; 77(2):e138-43. PubMed ID: 26930527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplementation with B vitamins or n-3 fatty acids and depressive symptoms in cardiovascular disease survivors: ancillary findings from the SUpplementation with FOLate, vitamins B-6 and B-12 and/or OMega-3 fatty acids (SU.FOL.OM3) randomized trial.
    Andreeva VA; Galan P; Torrès M; Julia C; Hercberg S; Kesse-Guyot E
    Am J Clin Nutr; 2012 Jul; 96(1):208-14. PubMed ID: 22648722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.
    Mocking RJ; Harmsen I; Assies J; Koeter MW; Ruhé HG; Schene AH
    Transl Psychiatry; 2016 Mar; 6(3):e756. PubMed ID: 26978738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
    Jiang W; Whellan DJ; Adams KF; Babyak MA; Boyle SH; Wilson JL; Patel CB; Rogers JG; Harris WS; O'Connor CM
    JACC Heart Fail; 2018 Oct; 6(10):833-843. PubMed ID: 30098961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementation of omega-3 fatty acids in parenteral nutrition beneficially alters phospholipid fatty acid pattern.
    Senkal M; Geier B; Hannemann M; Deska T; Linseisen J; Wolfram G; Adolph M
    JPEN J Parenter Enteral Nutr; 2007; 31(1):12-7. PubMed ID: 17202435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipids, depression and suicide].
    Colin A; Reggers J; Castronovo V; Ansseau M
    Encephale; 2003; 29(1):49-58. PubMed ID: 12640327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids.
    Cao J; Schwichtenberg KA; Hanson NQ; Tsai MY
    Clin Chem; 2006 Dec; 52(12):2265-72. PubMed ID: 17053155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
    Martins JG
    J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory response following heart surgery and association with n-3 and n-6 long-chain polyunsaturated fatty acids in plasma and red blood cell membrane lipids.
    Bjorgvinsdottir L; Indridason OS; Heidarsdottir R; Skogstrand K; Arnar DO; Torfason B; Hougaard DM; Palsson R; Skuladottir GV
    Prostaglandins Leukot Essent Fatty Acids; 2013 Sep; 89(4):189-94. PubMed ID: 23999253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.